SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-054465
Filing Date
2024-05-07
Accepted
2024-05-07 16:05:55
Documents
88
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rckt-20240331.htm   iXBRL 10-Q 1649867
2 EX-10.1 rckt-ex10_1.htm EX-10.1 96274
3 EX-31.1 rckt-ex31_1.htm EX-31.1 15068
4 EX-31.2 rckt-ex31_2.htm EX-31.2 15193
5 EX-32.1 rckt-ex32_1.htm EX-32.1 11595
6 GRAPHIC img173859252_0.jpg GRAPHIC 388821
7 GRAPHIC img173859252_1.jpg GRAPHIC 140884
  Complete submission text file 0000950170-24-054465.txt   9840673

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rckt-20240331.xsd EX-101.SCH 1345082
91 EXTRACTED XBRL INSTANCE DOCUMENT rckt-20240331_htm.xml XML 1635649
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 24921779
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)